Matches in Wikidata for { <http://www.wikidata.org/entity/Q64087311> ?p ?o ?g. }
- Q64087311 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q64087311 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64087311 description "scientific article published on 25 April 2019" @default.
- Q64087311 description "wetenschappelijk artikel" @default.
- Q64087311 description "наукова стаття, опублікована у квітні 2019" @default.
- Q64087311 description "գիտական հոդված հրատարակված 2019 թվականի ապրիլի 25-ին" @default.
- Q64087311 name "Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and se" @default.
- Q64087311 name "Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor" @default.
- Q64087311 type Item @default.
- Q64087311 label "Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and se" @default.
- Q64087311 label "Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor" @default.
- Q64087311 prefLabel "Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and se" @default.
- Q64087311 prefLabel "Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor" @default.
- Q64087311 P1433 Q64087311-C66C5038-AA1B-4701-AEC9-03A2006DFC7D @default.
- Q64087311 P1476 Q64087311-6BC06665-BDA5-49D0-8831-48FE32898C50 @default.
- Q64087311 P2093 Q64087311-36149551-0FDE-4C4C-A50E-A077975B55C3 @default.
- Q64087311 P2093 Q64087311-83B7172C-67A6-477F-B19D-717498321A97 @default.
- Q64087311 P2093 Q64087311-84A276B3-7E4A-4697-A812-5B7E6B981E13 @default.
- Q64087311 P2093 Q64087311-B2D48936-D40C-40AF-8F22-733A235A8A6F @default.
- Q64087311 P2093 Q64087311-FD51685B-FF94-4C87-B2DF-05B9B1511B66 @default.
- Q64087311 P2093 Q64087311-FD758BE1-5321-4079-A3B3-88984A18CE98 @default.
- Q64087311 P275 Q64087311-4e7efe74-6c1f-4606-908c-d439e9cce5ba @default.
- Q64087311 P2860 Q64087311-0927D84A-6F28-47D9-820B-3BBC1F1B3B71 @default.
- Q64087311 P2860 Q64087311-09CCB3C3-47A0-4E86-9B28-1F902BBB290D @default.
- Q64087311 P2860 Q64087311-0C22B1DF-BAE9-4F58-9667-AC0CD942ADB0 @default.
- Q64087311 P2860 Q64087311-12461FF3-1C0F-4BE3-A7C5-7D5785466323 @default.
- Q64087311 P2860 Q64087311-4E89E548-A7B0-42C2-83BB-50C6940D8336 @default.
- Q64087311 P2860 Q64087311-54D52265-9081-42B4-95EE-8B3212513487 @default.
- Q64087311 P2860 Q64087311-5B70E816-ED96-4AE4-A5F8-205EDC6D5CF2 @default.
- Q64087311 P2860 Q64087311-69C72298-F6F5-4BF5-BC94-96F58304D4BD @default.
- Q64087311 P2860 Q64087311-6BF870CC-879C-462B-9567-96C5956CB93C @default.
- Q64087311 P2860 Q64087311-71FA659E-D231-4F3F-A867-3A7589814196 @default.
- Q64087311 P2860 Q64087311-88BE2189-4DFC-4299-A94E-6786B23B7A72 @default.
- Q64087311 P2860 Q64087311-891DCFCB-EE22-406B-B18C-69E6FB058F16 @default.
- Q64087311 P2860 Q64087311-8D73183B-1D7C-45CA-9613-4FCEF97C2C4E @default.
- Q64087311 P2860 Q64087311-9EE84FF4-86E2-4738-8367-6D602B16FC76 @default.
- Q64087311 P2860 Q64087311-A3F4B577-9470-4E6F-B8AF-A05A211346E4 @default.
- Q64087311 P2860 Q64087311-A4E334BD-2FE7-412F-8A25-DE1527A14581 @default.
- Q64087311 P2860 Q64087311-A8CF31EF-1E9D-448E-B2FD-FF393A69DDE9 @default.
- Q64087311 P2860 Q64087311-A9B76445-237E-41F2-BE54-1312926141D1 @default.
- Q64087311 P2860 Q64087311-AABA799C-4A1C-4718-B589-FE0967AB1431 @default.
- Q64087311 P2860 Q64087311-B8BB3531-A9BD-43C1-914E-B45E5CEECDD8 @default.
- Q64087311 P2860 Q64087311-BFEDA103-2319-477C-A08F-2565A8B7CEBB @default.
- Q64087311 P2860 Q64087311-C9203657-6986-4696-BFE4-883762E5C1B9 @default.
- Q64087311 P2860 Q64087311-DE12BCE2-1E65-4C01-873E-3705997E1EF9 @default.
- Q64087311 P2860 Q64087311-E5B5E19D-112B-4998-957A-E52A72AA342F @default.
- Q64087311 P2860 Q64087311-E9C4238F-8981-470C-82EE-BE4293957B66 @default.
- Q64087311 P2860 Q64087311-EE4902EC-4C80-473C-BE20-ED7052D9BB44 @default.
- Q64087311 P2860 Q64087311-EE6087FC-7F0C-49C7-8EFD-F00E245F7BBD @default.
- Q64087311 P2860 Q64087311-F5F406BA-F431-455A-938D-87FA468E43B0 @default.
- Q64087311 P304 Q64087311-70B358EC-D819-4A04-A8B3-6DBEEE592D64 @default.
- Q64087311 P31 Q64087311-505F1A31-F171-4465-A1A8-4C8E4F04D0EB @default.
- Q64087311 P356 Q64087311-440A686C-A551-49D4-9BCC-B93E4FEC9F68 @default.
- Q64087311 P407 Q64087311-ACF009BC-B68C-48D2-8855-0AEBE8100392 @default.
- Q64087311 P433 Q64087311-9E3D5DD0-6FCE-4709-A591-B6117E06C488 @default.
- Q64087311 P478 Q64087311-17D4139C-A885-4397-B0C7-09175FBA738E @default.
- Q64087311 P50 Q64087311-D9DCE0A2-B0FA-4358-8BA0-02ECD13DF98F @default.
- Q64087311 P577 Q64087311-E0E7AB88-B9D4-42B2-972F-08819694FB3A @default.
- Q64087311 P6216 Q64087311-c28c1114-54c9-45b6-b97c-dbfd86420258 @default.
- Q64087311 P698 Q64087311-4E95F4E8-E60B-4081-81AC-12B4338F660C @default.
- Q64087311 P932 Q64087311-57E693D0-2B8B-44B1-BF84-BECB885CB0DC @default.
- Q64087311 P356 S12885-019-5507-6 @default.
- Q64087311 P698 31023244 @default.
- Q64087311 P1433 Q326300 @default.
- Q64087311 P1476 "Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials" @default.
- Q64087311 P2093 "Aileen Clarke" @default.
- Q64087311 P2093 "Alexander Tsertsvadze" @default.
- Q64087311 P2093 "G J Melendez-Torres" @default.
- Q64087311 P2093 "Lazaros Andronis" @default.
- Q64087311 P2093 "Martin Connock" @default.
- Q64087311 P2093 "Pamela Royle" @default.
- Q64087311 P275 Q20007257 @default.
- Q64087311 P2860 Q21195843 @default.
- Q64087311 P2860 Q27853359 @default.
- Q64087311 P2860 Q27860509 @default.
- Q64087311 P2860 Q29547546 @default.
- Q64087311 P2860 Q29620902 @default.
- Q64087311 P2860 Q29620913 @default.
- Q64087311 P2860 Q33407582 @default.
- Q64087311 P2860 Q34133344 @default.
- Q64087311 P2860 Q34148380 @default.
- Q64087311 P2860 Q34547495 @default.
- Q64087311 P2860 Q34658812 @default.
- Q64087311 P2860 Q34662482 @default.
- Q64087311 P2860 Q35061982 @default.
- Q64087311 P2860 Q35223735 @default.
- Q64087311 P2860 Q36540162 @default.
- Q64087311 P2860 Q37394447 @default.
- Q64087311 P2860 Q37877688 @default.
- Q64087311 P2860 Q38544205 @default.
- Q64087311 P2860 Q39714017 @default.
- Q64087311 P2860 Q40163779 @default.
- Q64087311 P2860 Q40408396 @default.
- Q64087311 P2860 Q40887724 @default.
- Q64087311 P2860 Q42281334 @default.
- Q64087311 P2860 Q46542092 @default.
- Q64087311 P2860 Q47104846 @default.
- Q64087311 P2860 Q53521886 @default.
- Q64087311 P2860 Q59587212 @default.
- Q64087311 P2860 Q90467174 @default.